Cargando…

Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate

Dengue virus (DENV) infection is the most common mosquito-transmitted viral infection. DENV infection can cause mild dengue fever or severe dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Hemorrhage and vascular leakage are two characteristic symptoms of DHF/DSS. However, due to the limi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hong-Ru, Lai, Yen-Chung, Yeh, Trai-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057007/ https://www.ncbi.nlm.nih.gov/pubmed/30037331 http://dx.doi.org/10.1186/s12929-018-0462-0

Ejemplares similares

Roles of Macrophage Migration Inhibitory Factor in Dengue Pathogenesis: From Pathogenic Factor to Therapeutic Target
por: Lai, Yen-Chung, et al.
Publicado: (2020)

Pathogenic Roles of Macrophage Migration Inhibitory Factor during Dengue Virus Infection
por: Chuang, Yung-Chun, et al.
Publicado: (2015)

Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection
por: Chuang, Yung-Chun, et al.
Publicado: (2013)

Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection
por: Lai, Yen-Chung, et al.
Publicado: (2017)

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis
por: Cheng, Yi-Ling, et al.
Publicado: (2022)

Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage
por: Chao, Chiao-Hsuan, et al.
Publicado: (2019)

Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model
por: Tien, Sen-Mao, et al.
Publicado: (2022)

Current progress in dengue vaccines
por: Wan, Shu-Wen, et al.
Publicado: (2013)

Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy
por: Chen, Hong-Ru, et al.
Publicado: (2016)

Dengue virus-induced ER stress is required for autophagy activation, viral replication, and pathogenesis both in vitro and in vivo
por: Lee, Ying-Ray, et al.
Publicado: (2018)

Dengue virus infection induces autophagy: an in vivo study
por: Lee, Ying-Ray, et al.
Publicado: (2013)

Autophagic machinery activated by dengue virus enhances virus replication
por: Lee, Ying-Ray, et al.
Publicado: (2008)

Multi-epitope vaccine candidate design for dengue virus
por: Dharani, A, et al.
Publicado: (2023)

Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1
por: Wan, Shu-Wen, et al.
Publicado: (2014)

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
por: Shukla, Rahul, et al.
Publicado: (2020)

A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine Candidates
por: Govindarajan, Dhanasekaran, et al.
Publicado: (2016)

Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability
por: Chen, Hong-Ru, et al.
Publicado: (2018)

Roles and Prospects of Dengue Virus Non-structural Proteins as Antiviral Targets: An Easy Digest
por: Norazharuddin, Hannah, et al.
Publicado: (2018)

Dengue Virus Enhances Thrombomodulin and ICAM-1 Expression through the Macrophage Migration Inhibitory Factor Induction of the MAPK and PI3K Signaling Pathways
por: Yeh, Trai-Ming, et al.
Publicado: (2013)

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties
por: Liu, Yan, et al.
Publicado: (2014)

Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus
por: Fadaka, Adewale Oluwaseun, et al.
Publicado: (2021)

Macrophage migration inhibitory factor induces vascular leakage via autophagy
por: Chen, Hong-Ru, et al.
Publicado: (2015)

Virus-like particles with FLAG-tagged envelope protein as a tetravalent dengue vaccine candidate
por: Imagawa, Toshifumi, et al.
Publicado: (2021)

Viral Interference Between Dengue Virus and Hepatitis C Virus Infections
por: Liang, Po-Cheng, et al.
Publicado: (2020)

Comparison of a dengue-2 virus and its candidate vaccine derivative: Sequence relationships with the flaviviruses and other viruses()
por: Blok, J., et al.
Publicado: (1992)

Assessing the Potential of a Candidate Dengue Vaccine with Mathematical Modeling
Publicado: (2012)

Conservation Analysis of Dengue Virus T-cell Epitope-Based Vaccine Candidates Using Peptide Block Entropy
por: Olsen, Lars Rønn, et al.
Publicado: (2011)

Long-term protection against dengue viruses in mice conferred by a tetravalent DNA vaccine candidate
por: Wang, Ran, et al.
Publicado: (2020)

Immature Dengue Virus: A Veiled Pathogen?
por: Rodenhuis-Zybert, Izabela A., et al.
Publicado: (2010)

Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication
por: Kao, Yi-Sheng, et al.
Publicado: (2023)

Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Δ30 with those of DEN1
por: Blaney, Joseph E, et al.
Publicado: (2007)

Peptides as Therapeutic Agents for Dengue Virus
por: Chew, Miaw-Fang, et al.
Publicado: (2017)

Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus
por: Baldwin, Whitney R., et al.
Publicado: (2021)

Dengue Virus Non-Structural Protein 5
por: El Sahili, Abbas, et al.
Publicado: (2017)

Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
por: Bal, Jyotiranjan, et al.
Publicado: (2018)

An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
por: Fernandez, Stefan, et al.
Publicado: (2015)

Effects of infection history on dengue virus infection and pathogenicity
por: Tsang, Tim K., et al.
Publicado: (2019)

Unbiased Identification of Dengue Virus Non-Structural Protein 1 Peptides for Use in Vaccine Design
por: Warner, Nikole L., et al.
Publicado: (2022)

Human antibody response to dengue virus: implications for dengue vaccine design
por: Moi, Meng Ling, et al.
Publicado: (2016)

Dengue Virus Non-Structural Protein 5 as a Versatile, Multi-Functional Effector in Host–Pathogen Interactions
por: Bhatnagar, Priya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_udb96eomhmdq6fho4duodirnhm